SynthesisFrontiers in cardiovascular medicine2026
Effects and safety of acupuncture on inflammatory biomarkers in patients with coronary heart disease: a systematic review and meta-analysis.
Synthesis in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation contributes to the development and progression of coronary heart disease (CHD), and residual inflammatory risk remains an important clinical concern despite advances in standard cardiovascular therapy. Acupuncture interventions have been increasingly used as adjunctive therapies for CHD, but their effects on inflammatory biomarkers have not been systematically evaluated. This systematic review and meta-analysis aimed to assess the effects of acupuncture interventions on inflammatory biomarkers and to evaluate their safety in patients with CHD. Methods: PubMed, Embase, the Cochrane Library, Web of Science, CNKI, Wanfang, VIP, and SinoMed were searched from inception to 12 March 2026. Randomized controlled trials evaluating acupuncture interventions in patients with CHD were included. The co-primary outcomes were high-sensitivity C-reactive protein (hs-CRP) and C-reactive protein (CRP). Secondary inflammatory outcomes included interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Meta-analyses were performed using Review Manager 5.4 and Stata 18.0. Random-effects 95% prediction intervals were calculated for heterogeneous inflammatory outcomes with at least three studies. Subgroup analyses were conducted by clinical setting, and a Results: Thirteen randomized controlled trials involving 927 patients were included. The pooled estimates were lower for CRP standardized mean difference (SMD) = -0.87, 95% confidence interval (CI) -1.43 to -0.30; 95% prediction interval (PI) -2.15 to 0.42; low-certainty evidence] and IL-6 (SMD = -0.74, 95% CI -1.31 to -0.17; 95% PI -1.93 to 0.45; low-certainty evidence), but heterogeneity was substantial and both prediction intervals included no effect. For hs-CRP, the pooled estimate was not statistically significant (SMD = -0.79, 95% CI -1.65 to 0.07; 95% PI -2.99 to 1.42), and the evidence remained inconclusive. TNF-α also favored acupuncture, but heterogeneity and imprecision were substantial. Total cholesterol (TC) and triglycerides (TG) decreased, whereas low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) did not differ significantly. Reported adverse events did not differ significantly between groups, but safety reporting was sparse. Conclusion: The pooled data yielded lower average CRP and IL-6 estimates, but low-certainty evidence, substantial heterogeneity, and prediction intervals including no effect preclude inference of a consistent anti-inflammatory benefit. Findings for hs-CRP and TNF-α were inconclusive. Current studies cannot distinguish acupuncture-specific effects from non-specific or contextual effects, and evidence on cardiovascular events and safety remains limited. Further well-designed trials are needed. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261279145.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.